Indi Molecular
2 known investors
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.
BiotechDeep TechMedical Devices
Investors · 2
In the news
- Indi Molecular - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Indi Molecular Raises $11.5M in Series A Funding - FinSMEsfinsmes.com · 2017
- BioCentury - Indi Molecular raises $11.5M in series A roundbiocentury.com · 2017
- Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Developmentglobenewswire.com · 2017
- Indi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partnersfinance.yahoo.com · 2013
- Indi Molecular - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com